SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zebra 365 who wrote (6121)3/25/1998 12:30:00 AM
From: VLAD  Read Replies (1) of 23519
 
Zebra,

I invested in Vivus based on my belief in MUSE and not on a competing drugs failure. My quote is based on short term price movement. I think that the lack of Viagra approval would help get rid of our undesired short factor thus at least giving us a rapid move back over 15. In the long run I completely agree with you and that is why I am in the Vivus game. Let Viagra approval be NOW so that the trial research can be carefully scrutinized by the scientific community rather than having to listen to Hugh's and Bawbwa WawWaw's sensationalism. MUSE and Viagra toe to toe, eye to eye and then hopefully the Street will wake up from it's Pfizer dream.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News